|
On July 8, McNeil
Consumer Products, marketer of Tylenol®, announced that its redesigned
label will include a revised alcohol warning statement by late July. As
proposed by FDA in November, the new warning will read: "If you drink
three or more alcoholic beverages every day, ask your doctor if you should
take Tylenol® or other pain relievers. Chronic heavy alcohol users
may be at increased risk of liver damage when taking more than the recommended
dose (overdose) of Tylenol®." This statement differs from the
FDA's proposed warning which linked any dosage of Tylenol® combined
with alcohol use to possible organ damage. The revised warning will appear
on adult regular Tylenol® and Extra Strength Tylenol®, but not
the extended-release form of Tylenol®. An alcohol warning related
to increased risk of stomach bleeding will also appear on Motrin IB®,
the ibuprofin product McNeil acquired from Pharmacia & Upjohn last
year. McNeil is the first manufacturer to adopt the organ-specific alcohol
warning proposed by FDA. |
|